Pet Drug Reports

Ingredients

Active ingredient · pooled across combinations

Vitamin D: adverse event reports, pooled

3 ingredient sets in reports · 1 FDA-approved application in the Green Book

74reports naming the ingredient, 1999–20260% of all reports · about 3 a year
9reports, 12 months to March 20267 in the 12 months before
42.2%classed serious, as reportedall reports: 38.6%
51.4%of reports concern exposed peopledog 31.1%

74 adverse event reports received by FDA list a drug containing vitamin d, alone or in combination, from April 1999 to February 2026. This page pools every ingredient set that includes it; 3 such sets appear in reports.

The Green Book lists 1 FDA-approved application containing it. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand.

9 reports arrived in the 12 months to March 2026, up 29% from 7 in the 12 months before. FDA posts reports quarterly with a delay of three to six months, so the newest months are incomplete and usually grow in later releases. That is about 3 reports a year over its reporting history and 0% of all reports.

Pooled across every set, the terms listed most often are accidental exposure (28.4%), diarrhoea (10.8%) and lethargy (10.8%). Many drugs combine several ingredients, and many reports list several drugs, so a term on this page may relate to any of them or to none.

Of reports that state seriousness, 42.2% were classed as serious (38.6% across the whole database); 14.9% record a death or euthanasia (6.4% overall). Ingredients used in older or sicker animals, or in anaesthesia and cancer care, carry higher shares for that reason alone.

Ingredient sets that include vitamin d

Active ingredients recorded for the drugReportsShare of this page's reportsLatest 12 months
Vitamin D6385.1%9
Vitamin A + Vitamin D + Vitamin E79.5%0
Vitamin A + Vitamin D45.4%0

Ordered by report count. FDA states that these data "cannot be used to estimate the risk associated with the product or compare one drug or device product with another"; counts follow sales volume and years on the market. A report can list more than one set, so shares can add to more than 100%.

Signs listed in reports, pooled

share of vitamin d reports listing the termall reports in the database

  1. Accidental exposure[exposure that was not intended]28.4%21
  2. Diarrhoea[diarrhea]10.8%8
  3. Lethargy[unusually tired or inactive]10.8%8
  4. Seizure NOS[seizure, type not specified]8.1%6
  5. Vocalisation[crying out or unusual noise]8.1%6
  6. Death6.8%5
  7. Dizziness6.8%5
  8. Death by euthanasia[the animal was euthanized]5.4%4
  9. Other abnormal test result NOS[abnormal laboratory result, type not specified]5.4%4
  10. Tachycardia[fast heart rate]5.4%4
  11. Anorexia[not eating]4.1%3
  12. Behavioural disorder NOS[behaviour change, type not specified]4.1%3
  13. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]4.1%3
  14. Emesis (multiple)[vomiting more than once]4.1%3
  15. Hind limb paresis[weak hind legs]4.1%3
  16. Lack of efficacy (endoparasite) - heartworm[the product did not have the expected effect: heartworm]4.1%3
  17. Lateral recumbency[lying on the side, unable to rise]4.1%3
  18. Mental impairment NOS[NOS: not otherwise specified]4.1%3
  19. Nausea4.1%3
  20. Staring4.1%3
  21. Tachypnoea[fast breathing]4.1%3

Pooled across every ingredient set and every report that names the ingredient. One report can list several terms and several drugs; a term here may relate to any of them or to none.

Monthly reports by species, five years

Dog6 · peak 1
Oct 2022: 1Jun 2023: 1Dec 2024: 1Feb 2025: 1Jul 2025: 1Jan 2026: 12022202320242025
Cat2 · peak 1
Sep 2024: 1Nov 2024: 12022202320242025
Horse1 · peak 1
Feb 2024: 12022202320242025
Other16 · peak 3
Apr 2021: 1Aug 2022: 1Oct 2022: 1Mar 2023: 1Apr 2023: 1Jul 2023: 1Apr 2024: 2Feb 2025: 1Jul 2025: 1Oct 2025: 2Jan 2026: 3Feb 2026: 12022202320242025

By month of receipt; each panel has its own scale. The newest months are incomplete because FDA posts reports with a delay of three to six months.

06121999: 119992000: 22002: 220022004: 12012: 620122014: 12015: 520152016: 12017: 520172018: 122019: 1020192020: 32021: 120212022: 32023: 420232024: 62025: 620252026: 5

Outcomes, report types and ages

Outcome recorded in the report

Recovered/Normal36.5%27
Recovered with Sequela0%0
Ongoing17.6%13
Died9.5%7
Euthanized5.4%4
Outcome Unknown31.1%23

What kind of report it was

Safety issue87.8%65
Lack of expected effectiveness8.1%6
Both safety and lack of expected effectiveness0%0
Manufacturing or product defect4.1%3
Other0%0

Species

Human exposure51.4%38
Dog31.1%23
Cattle6.8%5
Cat5.4%4
Alpaca1.4%1
Horse1.4%1

Age of the animal

Under 1 year2.7%2
1 to 3 years12.2%9
4 to 7 years9.5%7
8 to 11 years10.8%8
12 years and over51.4%38
Age not given13.5%10

Coloured bar: reports naming vitamin d. Grey bar: all 1,357,245 reports. Outcomes are as stated by the reporter; FDA has not necessarily determined whether any product played a part.

In context

MeasureVitamin DAll reports
Reports741,357,245
Latest 12 months against the 12 before+29%-5%
Classed serious, of reports stating it42.2%38.6%
Death or euthanasia recorded, per 1,000 reports148.663.8
Filed as lack of expected effectiveness (wholly or partly)8.1%23%

Shares of reports, not of animals treated: how many animals receive the ingredient is not public. Ingredients used in anaesthesia, cancer care or in old animals carry more serious outcomes in their reports for that reason alone.

FDA-approved products containing vitamin d (Green Book)

Reference information, not report statistics. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The list below is the FDA Green Book as of 30 Sep 2026; nothing on this page says which of these products, if any, a report concerned.

Trade nameActive ingredientsSponsorApproved forApplication
Tylan Plus Vitaminsapproval voluntarily withdrawnFolic Acid, Pyridoxine Hydrochloride, Tylosin, Vitamin A, Vitamin B1, Vitamin B2, Vitamin B5, Vitamin D, Vitamin EElanco Animal Health, A Division of Eli Lilly & Co.—NADA 013-029

Species are the major species the Green Book search lists for the application ("—" where it lists another species or none). Approval dates are not part of the Green Book listing files and are not shown. Pioneer applications (NADA) come first, then generics (ANADA).

Questions about vitamin d reports

How many FDA adverse event reports mention vitamin d?

74 reports through March 2026, 9 of them in the latest 12 months, counting vitamin d alone and in combinations.

Which brands do these reports concern?

That cannot be known from the public data. openFDA masks brand and manufacturer names in adverse event records, so the reports counted here cannot be attributed to a particular brand. The Green Book reference list on this page names approved products containing vitamin d without any counts.

In which combinations is vitamin d reported?

Vitamin D (85.1% of these reports), Vitamin A + Vitamin D + Vitamin E (9.5% of these reports) and Vitamin A + Vitamin D (5.4% of these reports).

What reactions are reported for vitamin d?

accidental exposure (28.4%), diarrhoea (10.8%), lethargy (10.8%), not eating (8.1%) and seizure NOS (8.1%). Shares are of reports naming the ingredient; one report can list several terms.

Which animals are these reports about?

human exposure (51.4%), dog (31.1%) and cattle (6.8%).

Does a high count mean vitamin d is a problem ingredient?

A count cannot show that. FDA states that "there is no certainty that the reported drug or device caused the adverse event" and that the event "may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources." Widely used ingredients collect more reports because more animals receive them.

How do I report a problem?

Call the drug company using the number on the label, or send Form FDA 1932a to FDA. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 30 Sep 2026. Ingredient names follow the Green Book; salts and forms are kept as FDA lists them. Drug entries are matched by the active ingredients their unmasked ingredient field discloses. No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.